Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today issued the following statement in response to the Federal Trade Commission's reckless insulin action: ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The Federal Trade Commission is suing the three largest prescription drug benefit managers (PBMs) for allegedly driving up ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback